In this video, Diane Mould, PhD, from Projections Research, discusses the important role of monoclonal antibodies in the management of inflammatory diseases.
Co-Chair Edward Shahady, MD, FAAFP, ABCL, interviews Kevin Peterson, MD, MPH, on what happens to Beta Cells after 3 years of GLP-1 administration, compared with insulin.
